In suspected opioid use disorder, what is an initial, evidence-based management strategy in primary care?

Study for the Medical Council of Canada Qualifying Examination (MCCQE) I. Engage with flashcards and multiple-choice questions with detailed feedback. Prepare confidently!

Multiple Choice

In suspected opioid use disorder, what is an initial, evidence-based management strategy in primary care?

The key idea is to start with identification and engagement in a patient-centered, evidence-based plan for suspected opioid use disorder in primary care. The best approach combines structured screening to identify the disorder, a brief intervention to motivate change, referral to appropriate addiction treatment, and the consideration of medication-assisted treatment with buprenorphine–naloxone when suitable, all while practicing safe opioid prescribing. Structured screening helps you detect OUD early using validated tools and DSM-5 criteria, normalizing the conversation and reducing stigma. A brief intervention, often using motivational interviewing, supports the patient in reflecting on their use and readiness to change, without pushing for abrupt or unsupported decisions. Referral to addiction treatment ensures access to specialized care, including behavioral therapies and ongoing support. When appropriate, starting buprenorphine–naloxone in primary care provides effective, evidence-based pharmacotherapy that reduces withdrawal and cravings and lowers overdose risk, while allowing ongoing engagement with the patient in a primary care setting. Safe-prescribing practices—such as using prescription monitoring, evaluating risk factors, avoiding risky co-prescriptions, employing urine drug screening when indicated, and offering naloxone—help mitigate harm and set the stage for recovery. Detoxification alone, especially without supportive treatment, often has high relapse rates and poor long-term outcomes. Prescribing higher-dose opioids would worsen the disorder and undermine recovery. Ignoring the patient’s concerns is not appropriate care.

The key idea is to start with identification and engagement in a patient-centered, evidence-based plan for suspected opioid use disorder in primary care. The best approach combines structured screening to identify the disorder, a brief intervention to motivate change, referral to appropriate addiction treatment, and the consideration of medication-assisted treatment with buprenorphine–naloxone when suitable, all while practicing safe opioid prescribing.

Structured screening helps you detect OUD early using validated tools and DSM-5 criteria, normalizing the conversation and reducing stigma. A brief intervention, often using motivational interviewing, supports the patient in reflecting on their use and readiness to change, without pushing for abrupt or unsupported decisions. Referral to addiction treatment ensures access to specialized care, including behavioral therapies and ongoing support. When appropriate, starting buprenorphine–naloxone in primary care provides effective, evidence-based pharmacotherapy that reduces withdrawal and cravings and lowers overdose risk, while allowing ongoing engagement with the patient in a primary care setting. Safe-prescribing practices—such as using prescription monitoring, evaluating risk factors, avoiding risky co-prescriptions, employing urine drug screening when indicated, and offering naloxone—help mitigate harm and set the stage for recovery.

Detoxification alone, especially without supportive treatment, often has high relapse rates and poor long-term outcomes. Prescribing higher-dose opioids would worsen the disorder and undermine recovery. Ignoring the patient’s concerns is not appropriate care.

More practice questions